Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-26-064653

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lindborg Stacy · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-26 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 $0.70 $105,000 150,000 D
Loading xslF345X06/tm267728-3_4seq1.xml…